Business Standard

Wednesday, December 25, 2024 | 06:34 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Vaccine makers ramp up production capacities despite low current demand

Booster shot, children vaccination, exports can spike demand in the future

Covishield
Premium

Employees pack boxes containing vials of AstraZeneca's Covishield vaccine at the Serum Institute of India, in Pune (Photo: AP/PTI)

Sohini Das Mumbai
Ahead of a much anticipated meeting to decide whether a third dose or a booster shot of the Covid-19 vaccines would be allowed in India, vaccine makers are working on continuously ramping up capacities. Apart from booster shots for sections of the population (immuno-compromised or frontline workers) once vaccination is opened up for children, demand is likely to see a rise.

Next week a meeting is expected to review the situation on allowing booster shots to at least some segments of the population. The drug regulator has not yet given a nod to start children vaccination, neither has the National

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in